Intuitive Surgical (ISRG) SVP exercises options and sells common shares

Rhea-AI Filing Summary

Intuitive Surgical executive Mark Brosius reported stock option exercises and share sales. As SVP & Chief Manufacturing and Supply Chain, he exercised 4,500 non-qualified stock options for common stock at an exercise price of $79.6378 per share on 12/12/2025, then sold 4,500 common shares that day at $547.36 per share.

He also sold 464 common shares on 12/15/2025 at $548.49 per share. After these transactions, he directly owned 443 shares of Intuitive Surgical common stock and held no remaining derivative securities from the reported option grant. The filing notes that the transactions were made under a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brosius Mark

(Last) (First) (Middle)

1020 KIFER ROAD

(Street)

SUNNYVALE CA 94086

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Chief Mfg and Supply Cha

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		M(1)		4,500	A	$79.6378	5,407	D
Common Stock	12/12/2025		S(1)		4,500	D	$547.36	907	D
Common Stock	12/15/2025		S(1)		464	D	$548.49	443	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$79.6378	12/12/2025		M(1)			4,500	(2)	02/15/2027	Common Stock	4,500	$0.0	0	D

Explanation of Responses:

1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.

2. Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

	By: Thanh Nhan Phan For: Brosius, Mark	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Intuitive Surgical (ISRG) report for Mark Brosius?

The report shows that Mark Brosius, an Intuitive Surgical officer, exercised 4,500 non-qualified stock options and sold common shares in two transactions on 12/12/2025 and 12/15/2025.

How many Intuitive Surgical (ISRG) shares did Mark Brosius sell and at what prices?

He sold 4,500 common shares on 12/12/2025 at $547.36 per share and 464 common shares on 12/15/2025 at $548.49 per share.

What stock options did Mark Brosius exercise in this Intuitive Surgical (ISRG) filing?

He exercised 4,500 non-qualified stock options with an exercise price of $79.6378 per share, originally granted under the 2010 Incentive Award Plan.

How many Intuitive Surgical (ISRG) shares does Mark Brosius own after these transactions?

Following the reported transactions, Mark Brosius directly owned 443 shares of Intuitive Surgical common stock.

Was the Intuitive Surgical (ISRG) insider trading activity under a Rule 10b5-1 plan?

Yes. The filing states the transactions took place under a Trading Plan that complies with SEC Rule 10b5-1, which expires on February 14, 2027.

What is Mark Brosius’s role at Intuitive Surgical (ISRG)?

Mark Brosius is an officer of Intuitive Surgical, serving as SVP & Chief Manufacturing and Supply Chain.